TC Biopharm (Holdings)
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $6,912,657.
Profit Margin
| 2019 | 3.42M | -6.06M | -177.07% |
|---|---|---|---|
| 2020 | 1.97M | -5.45M | -275.84% |
| 2021 | 1.97M | -13.57M | -686.12% |
| 2022 | 3.84M | -1.38M | -36.15% |
| 2023 | 0 | -5.90M |
TCBPW Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 3.84M | 1.97M | 1.97M | 3.42M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 3.84M | 1.97M | 1.97M | 3.42M |
Operating exp. | |||||
Research and development | 7.77M | 7.44M | 6.15M | 6.67M | 8.61M |
Selling and marketing | 402.31K | 0 | 0 | 0 | 0 |
Total operating expenses | 6.91M | 15.76M | 9.25M | 8.31M | 10.06M |
Operating income | -14.23M | -12.05M | -7.28M | -6.88M | -6.61M |
Other income (expenses), net | 7.24M | 8.94M | -7.70M | -291.03K | -275.41K |
Income before tax | -6.99M | -3.10M | -14.98M | -6.62M | -6.89M |
Income tax expense | -1.08M | -1.72M | -1.40M | 1.17M | -826.06K |
Net income | -5.90M | -1.38M | -13.57M | -5.45M | -6.06M |
Earnings per share | |||||
Basic EPS | -191.21 | -40.45 | -695.2 | -2.88K | -338.67 |
Diluted EPS | -191.21 | -40.45 | -695.17 | -2.88K | -338.65 |
| Data source | Data source | Data source |